A Potent HER3 Monoclonal Antibody That Blocks Both Ligand-Dependent and -Independent Activities: Differential Impacts of PTEN Status on Tumor Response

Molecular Cancer Therapeutics
Zhan XiaoDavid A Tice

Abstract

HER3/ERBB3 is a kinase-deficient member of the EGFR family receptor tyrosine kinases (RTK) that is broadly expressed and activated in human cancers. HER3 is a compelling cancer target due to its important role in activation of the oncogenic PI3K/AKT pathway. It has also been demonstrated to confer tumor resistance to a variety of cancer therapies, especially targeted drugs against EGFR and HER2. HER3 can be activated by its ligand (heregulin/HRG), which induces HER3 heterodimerization with EGFR, HER2, or other RTKs. Alternatively, HER3 can be activated in a ligand-independent manner through heterodimerization with HER2 in HER2-amplified cells. We developed a fully human mAb against HER3 (KTN3379) that efficiently suppressed HER3 activity in both ligand-dependent and independent settings. Correspondingly, KTN3379 inhibited tumor growth in divergent tumor models driven by either ligand-dependent or independent mechanisms in vitro and in vivo Most intriguingly, while investigating the mechanistic underpinnings of tumor response to KTN3379, we discovered an interesting dichotomy in that PTEN loss, a frequently occurring oncogenic lesion in a broad range of cancer types, substantially blunted the tumor response in HER2-amplified can...Continue Reading

References

Jun 1, 1994·Molecular and Cellular Biology·S P SoltoffL C Cantley
Aug 16, 1994·Proceedings of the National Academy of Sciences of the United States of America·P M GuyK L Carraway
Apr 29, 1999·Proceedings of the National Academy of Sciences of the United States of America·L N KlapperY Yarden
Dec 21, 2004·International Journal of Cancer. Journal International Du Cancer·Christophe StoveMarc Bracke
Jun 24, 2006·The Journal of Biological Chemistry·William F Dall'AcquaHerren Wu
Aug 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christoph A RitterCarlos L Arteaga
Jul 18, 2008·Cancer Research·Si Tuen Lee-HoeflichHoward M Stern
Mar 11, 2010·Cancer Research·Birgit SchoeberlKwok-Kin Wong
Mar 4, 2011·Proceedings of the National Academy of Sciences of the United States of America·Anindita ChakrabartyCarlos L Arteaga
Mar 10, 2011·Proceedings of the National Academy of Sciences of the United States of America·Joan T GarrettCarlos L Arteaga
Jul 13, 2012·Nature Reviews. Cancer·Yosef Yarden, Gur Pines
Oct 25, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sarat ChandarlapatyTari A King
May 8, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brent N RexerCarlos L Arteaga
Nov 19, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·William R Gwin, Neil L Spector
Oct 16, 2015·Proceedings of the National Academy of Sciences of the United States of America·Sangwon LeeJoseph Schlessinger

❮ Previous
Next ❯

Citations

Sep 27, 2018·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Inez LamFeilim Mac Gabhann
Jul 31, 2018·Oncology Reviews·Rosalin MishraJoan T Garrett
Aug 24, 2019·JCO Precision Oncology·Daniel L FadenUmamaheswar Duvvuri
Mar 10, 2019·Nature Reviews. Drug Discovery·Jennifer E Kung, Natalia Jura
Dec 22, 2016·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Niki KarachaliouRafael Rosell
Jul 21, 2017·PloS One·Diego AlvaradoTheresa M LaVallee
Feb 14, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Carlos D MartinsGabriela Kramer-Marek
Dec 18, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Toni M BrandJennifer R Grandis
Jun 20, 2021·Nature Communications·Florian KastAndreas Plückthun

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Sangwon LeeJoseph Schlessinger
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer
Tanja Schneider-Merck, Martin Trepel
© 2022 Meta ULC. All rights reserved